Research Article
Chemokine Profiles Are Affected in Serum of Patients with Acute Rejection of Kidney Allograft
Table 1
The demographic characteristics and clinical features of study groups.
| | Normal outcome | Rejection |
| | Number of patients () | 94 | 44 | | Type of acute rejection (, %) | | Cellular | | 16 (36.4) | | Humoral/DSA+ | | 13 (29.5) | | Humoral/DSA- | | 15 (34.1) | | Gender (male/female) () | 61/33 | 28/16 | | Recipient age (median, range) | 58 (22-80) | 54 (23-79) | | Donor age (median, range) | 56.5 (1-81) | 51 (21-75) | | Cold ischemia time (hours) (median, range) | 14 (0-24) | 15 (0-21) | | PRA (%) (median, range) | 10 (0-98) | 10 (0-92) | | HLA mismatches (median, range) | 3 (1-6) | 3 (0-6) | | DSA positivity (, %) | | Preformed DSA | 8 (8.5) | 14 (31.8) | | De novo DSA | 0 | 5 (11.4) | | Induction therapy (, %) | | Basiliximab | 27 (28.7) | 16 (36.4) | | ATG | 59 (62.8) | 18 (40.9) | | ATG, PE, IVIG | 8 (8.5) | 10 (22.7) | | Maintenance IS (, %) | | TAC, MMF, CS | 86 (91.5) | 39 (88.6) | | TAC, KS | 5 (5.3) | 5 (11.4) | | mTOR, MMF, CS | 3 (3.2) | 0 (0) |
|
|
